 |
 |
 |
|
Response-guided interferon add-on to bulevirtide treatment: updated real-world insights from the austrian hepatitis D cohort study
|
|
|
EASL May 7-10 Amsterdam
Michael Schwarz1, Caroline Schwarz1,2, Marlene Panzer3, Nikolaus Pfisterer4, Nina Loschko5, Lukas Hartl1, Livia Dorn6, Hermann Laferl7, Michael Trauner, Albert Friedrich Stättermayer1, Mattias Mandorfer, Ivo Graziadei8, Andreas Maieron6,
Alexander Moschen5, Elmar Aigner9, Christian Madl4,10, Stephan Aberle11, Heinz Zoller3, Michael Gschwantler2,10, Thomas Reiberger, Mathias Jachs.







|
|
|
 |
 |
|
|